Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Venus Remedies Limited ( (IN:VENUSREM) ) just unveiled an update.
Venus Remedies has notified stock exchanges that it has used its official social media channels to inform shareholders about a special window for re-lodgement of transfer requests for physical shares. The communication aligns with recent Securities and Exchange Board of India guidelines, signaling the company’s efforts to ensure regulatory compliance and improve investor awareness around legacy physical share transfers, which may affect how some investors regularise their holdings.
More about Venus Remedies Limited
Venus Remedies Limited is an India-based pharmaceutical company with manufacturing units in Haryana and elsewhere, and an international arm, Venus Pharma GmbH in Germany. The company operates in the healthcare sector, focusing on the development and production of pharmaceutical formulations for domestic and global markets.
Average Trading Volume: 2,320
Technical Sentiment Signal: Buy
Current Market Cap: 10.1B INR
For an in-depth examination of VENUSREM stock, go to TipRanks’ Overview page.